Clinical Trial Update: Study of Efficacy and Safety of LEE011 in Men and Postmenopausal Women With Advanced Breast Cancer. [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating efficacy and safety of LEE011 (ribociclib) in men and postmenopausal women with advanced breast cancer has completed with results poste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• LEE011 (ribociclib)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Advanced Breast Cancer | Phase 3 | Status: COMPLETED | Results posted: 2018-09-19